Ronald Kamdem
Stock Analyst at Morgan Stanley
(3.83)
# 541
Out of 4,814 analysts
189
Total ratings
52.58%
Success rate
6.14%
Average return
Main Sectors:
Stocks Rated by Ronald Kamdem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAC The Macerich Company | Maintains: Equal-Weight | $20 → $19 | $14.66 | +29.60% | 2 | Apr 1, 2025 | |
| LINE Lineage | Maintains: Overweight | $80 → $75 | $55.99 | +33.95% | 2 | Apr 1, 2025 | |
| AHR American Healthcare REIT | Maintains: Overweight | $36 → $37 | $30.29 | +22.17% | 4 | Mar 25, 2025 | |
| PGRE Paramount Group | Maintains: Equal-Weight | $4.25 → $4 | $4.28 | -6.43% | 6 | Mar 18, 2025 | |
| HPP Hudson Pacific Properties | Maintains: Underweight | $2.4 → $2.25 | $2.29 | -1.53% | 10 | Mar 18, 2025 | |
| VNO Vornado Realty Trust | Maintains: Equal-Weight | $26 → $28 | $34.44 | -18.70% | 7 | Mar 14, 2025 | |
| CBRE CBRE Group | Maintains: Overweight | $160 → $165 | $117.45 | +40.49% | 3 | Feb 19, 2025 | |
| CURB Curbline Properties | Initiates: Equal-Weight | $27 | $23.17 | +16.53% | 1 | Jan 29, 2025 | |
| GLPI Gaming and Leisure Properties | Downgrades: Equal-Weight | $53 | $49.51 | +7.05% | 4 | Jan 15, 2025 | |
| FVR FrontView REIT | Maintains: Overweight | $23 → $22 | $12.31 | +78.72% | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $25 | $21.91 | +14.13% | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $293 → $315 | $296.00 | +6.42% | 17 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $133 | $102.08 | +30.29% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $62 | $58.32 | +6.31% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $108 | $147.27 | -27.00% | 5 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 | $32.54 | +1.41% | 4 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $7.28 | -3.85% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.8 → $1.6 | $0.37 | +338.36% | 15 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $18 → $21 | $27.57 | -23.83% | 10 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $145 | $150.39 | -3.58% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $14 → $18 | $18.26 | -1.42% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $62 → $75 | $71.77 | +4.50% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $115 → $150 | $141.00 | +6.38% | 20 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $32 | $36.72 | -12.85% | 20 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $47 | $67.75 | -30.63% | 3 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $24 | $15.18 | +54.81% | 7 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $38 → $35 | $52.35 | -33.15% | 5 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $67 | $63.83 | +4.97% | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $16.09 | +18.09% | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $46 | $41.89 | +9.81% | 6 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $77 → $73 | $79.04 | -7.64% | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $195 → $150 | $159.67 | -6.06% | 1 | Oct 17, 2022 |
The Macerich Company
Apr 1, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $14.66
Upside: +29.60%
Lineage
Apr 1, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $55.99
Upside: +33.95%
American Healthcare REIT
Mar 25, 2025
Maintains: Overweight
Price Target: $36 → $37
Current: $30.29
Upside: +22.17%
Paramount Group
Mar 18, 2025
Maintains: Equal-Weight
Price Target: $4.25 → $4
Current: $4.28
Upside: -6.43%
Hudson Pacific Properties
Mar 18, 2025
Maintains: Underweight
Price Target: $2.4 → $2.25
Current: $2.29
Upside: -1.53%
Vornado Realty Trust
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $26 → $28
Current: $34.44
Upside: -18.70%
CBRE Group
Feb 19, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $117.45
Upside: +40.49%
Curbline Properties
Jan 29, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $23.17
Upside: +16.53%
Gaming and Leisure Properties
Jan 15, 2025
Downgrades: Equal-Weight
Price Target: $53
Current: $49.51
Upside: +7.05%
FrontView REIT
Jan 3, 2025
Maintains: Overweight
Price Target: $23 → $22
Current: $12.31
Upside: +78.72%
Dec 13, 2024
Initiates: Equal-Weight
Price Target: $25
Current: $21.91
Upside: +14.13%
Oct 2, 2024
Maintains: Equal-Weight
Price Target: $293 → $315
Current: $296.00
Upside: +6.42%
Aug 14, 2024
Maintains: Overweight
Price Target: $132 → $133
Current: $102.08
Upside: +30.29%
Aug 6, 2024
Reinstates: Equal-Weight
Price Target: $62
Current: $58.32
Upside: +6.31%
Jul 11, 2024
Maintains: Overweight
Price Target: $103 → $108
Current: $147.27
Upside: -27.00%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $33
Current: $32.54
Upside: +1.41%
Apr 10, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $7.28
Upside: -3.85%
Mar 28, 2024
Maintains: Underweight
Price Target: $1.8 → $1.6
Current: $0.37
Upside: +338.36%
Mar 28, 2024
Maintains: Underweight
Price Target: $18 → $21
Current: $27.57
Upside: -23.83%
Feb 26, 2024
Maintains: Equal-Weight
Price Target: $143 → $145
Current: $150.39
Upside: -3.58%
Dec 21, 2023
Upgrades: Equal-Weight
Price Target: $14 → $18
Current: $18.26
Upside: -1.42%
Dec 21, 2023
Upgrades: Overweight
Price Target: $62 → $75
Current: $71.77
Upside: +4.50%
Dec 21, 2023
Upgrades: Equal-Weight
Price Target: $115 → $150
Current: $141.00
Upside: +6.38%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $42 → $32
Current: $36.72
Upside: -12.85%
Sep 7, 2023
Maintains: Equal-Weight
Price Target: $45 → $47
Current: $67.75
Upside: -30.63%
Jul 5, 2023
Maintains: Equal-Weight
Price Target: $30 → $24
Current: $15.18
Upside: +54.81%
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $38 → $35
Current: $52.35
Upside: -33.15%
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $68 → $67
Current: $63.83
Upside: +4.97%
Dec 16, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $16.09
Upside: +18.09%
Nov 2, 2022
Maintains: Equal-Weight
Price Target: $45 → $46
Current: $41.89
Upside: +9.81%
Nov 2, 2022
Maintains: Overweight
Price Target: $77 → $73
Current: $79.04
Upside: -7.64%
Oct 17, 2022
Maintains: Equal-Weight
Price Target: $195 → $150
Current: $159.67
Upside: -6.06%